StocksMedium•6 November 2026•
1 min read
Immunocore Reports $102.2 Million in Q3 KIMMTRAK Revenue
Key Facts
1Immunocore reported KIMMTRAK net revenues of $102.2 million for the third quarter of 2026.
2Net revenues for the first nine months of 2026 reached $324.8 million, representing 10% year-over-year growth.
Immunocore reported KIMMTRAK net revenues of $102.2 million for the third quarter of 2026. According to GlobeNewswire, net revenues for the first nine months of 2026 reached $324.8 million, representing a 10% increase compared to the same period in the previous year.
Third-quarter sales included $62.2 million from the United States and $34.9 million from Europe, while the company held $901.3 million in cash and marketable securities as of September 30, 2026. IMCR closed at $28.4 on November 5, 2026.